⚠ You're viewing a report from January 2024. Subscribe to get the latest →

FDA Enforcement — January 2024 Report

Automated analysis of 41 items from public government data sources. Updated daily.

Summary

41
Total items
18
High impact
23
Medium impact
0
Low impact

High-impact items this period

Les Importations Herbasanté Inc.
Pharmaceutical finished products adulterated CGMP violations
Why: Current Good Manufacturing Practice non-compliance in pharmaceutical production  ·  Jan 31  ·  Impact: HIGH
Barsotti Juice Company, Inc.
Juice HACCP violations and insanitary conditions detected
Why: Manufacturing facility failed to maintain sanitary conditions and proper HACCP protocols  ·  Jan 30  ·  Impact: HIGH
Inmar Supply Chain Solutions, LLC
Food adulterated from insanitary manufacturing and handling
Why: Failure to maintain sanitary conditions during food manufacturing and packing  ·  Jan 30  ·  Impact: HIGH
Soulaire Corporation
Investigational device exemption adulterated device violation
Why: Device failed to meet safety or performance standards during IDE/PMA process  ·  Jan 29  ·  Impact: HIGH
Nobles Medical Technology II, Inc.
Investigational review board compliance violations
Why: IRB oversight deficiencies in clinical investigations  ·  Jan 26  ·  Impact: HIGH
S & J International Enterprises Public Company Limited
CGMP violation - adulterated finished pharmaceutical products
Why: Manufacturing process failures or quality control deficiencies in drug production  ·  Jan 26  ·  Impact: HIGH
QuVa Pharma, Inc.
Compounding pharmacy produced adulterated drug products
Why: Violation of compounding pharmacy CGMP standards  ·  Jan 26  ·  Impact: HIGH
Lucky K.T. Co., Inc.
CGMP violations and insanitary manufacturing conditions
Why: Unsanitary conditions in food manufacturing, packing or holding operations  ·  Jan 26  ·  Impact: HIGH
Agila Corporation dba Woody’s Pet Food Deli
CGMP and preventive controls violations in pet food manufacturing
Why: Pet food facility failed hazard analysis and preventive control protocols  ·  Jan 26  ·  Impact: HIGH
Colgin, Inc.
CGMP violations in finished pharmaceutical operations
Why: Manufacturing facility failed to maintain current good manufacturing practices  ·  Jan 25  ·  Impact: HIGH

Selected medium-impact items

Barkey GmbH & Co. KG
Investigational device exemption and premarket approval violations
Why: Non-compliance with IDE/PMA regulatory requirements  ·  Jan 31  ·  Impact: MEDIUM
Cheap MistHub
Tobacco product adulteration and misbranding violation
Why: Unapproved tobacco product claims or prohibited marketing practices  ·  Jan 31  ·  Impact: MEDIUM
Nico Choice LLC
Tobacco product adulteration and misbranding violation
Why: Unapproved tobacco product claims or prohibited marketing practices  ·  Jan 31  ·  Impact: MEDIUM
AT Vapors LLC
Tobacco product adulteration and misbranding violation
Why: Unapproved tobacco product claims or prohibited marketing practices  ·  Jan 31  ·  Impact: MEDIUM
Vapingfly
Tobacco product adulteration and misbranding violation
Why: Unapproved tobacco product claims or prohibited marketing practices  ·  Jan 31  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →